Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi
Switzerland is seen as a small but still attractive market for pharmaceuticals, even though that the Swiss decision-makers are considered as tough and sometimes even difficult. A core issue might especially be, that the assessment and negotiations primarily happen intransparently „behind the doors“.
Dr. Heiner Sandmeier has been part of the drug evaluation committee advising the Swiss decision makers for over a century and opens his insights and secrets to all listeners.
Some of the topics Dr. Sandmeier and reimbursement veteran Dr. Stefan Walzer discuss are as follows:
- What are the main drivers for a positive decision in Switzerland?
- Who is involved in the decision process?
- What are the challenges as well as possible solutions for the main issues?
- What are the differences to other countries in Europe?
And last but not least: Why should you still consider to enter the Swiss market with an innovative pharmaceutical product?
✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb
MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #pricingstrategy #negotiations #pricing #pharmaceuticals #switzerland #innovation #reimbursement
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi
We are living in an age of massive medical innovation including a lot of new modalities especially in the area of ATMPs, but also beyond. Within this area, but obviously also beyond, there are core questions in the area of tensions such as the followings:
- What are the differences between Clinical Development and Medical Affairs?
- When should a company start telling their medical story about a new product?
- What are the differences between drugs and vaccinations from a medical affairs’ perspective?
- And how should market access and medical affairs ideally work together?
Market access veteran Dr. Stefan Walzer and Dr. Mike Rosenblatt, one of the pioneers in Medical Affairs, Commercialisation and Market Access continued their come together in Boston in May 2023 in this epic podcast episode.
Don’t miss this amazing conversation.
✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb
MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #medicalaffairs #pricingstrategy #negotiations
#pricing #medtech #pharmaceuticals #usa #innovation #vaccination
🎧 Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi
🇨🇭Switzerland has one of the highest healthcare spendings per person across the world! At the same time, one could also say that Switzerland has also one of the best healthcare systems...
💥 … but health care expert Dr. Peter Intra calls it still a developing country in terms of digitalisation! In this MAP podcast episode, health care system veteran Dr. Stefan Walzer and Dr. Peter Intra are discussing the current state of digital health in Switzerland, possible improvements and the inspiring example of Estonia.
What are we talking about, when we address the topic of digitalisation and e-health?
- Data + AI, which is dealing with the data
- Infrastructure like electronic patient record and vaccination registries
- Processes
Don't miss this inspiring conversation with spill-overs for all countries around the world.
✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb
MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf
#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #digitization #digitalhealth #funding #ehealth #healthcare #digitalisation #healthservices #switzerland